Quantum Biopharma QNTM
NASDAQ QNTM
$2.24 -0.03 (-1.32%)
At close: Oct 23, 2026 · 4:00 PM EDT

Quantum Biopharma (QNTM) Gains from Sales and Divestitures (2025)

Updated

Quantum Biopharma (QNTM) reported Gains from Sales and Divestitures of $4,290 for Q2 2026, down 93.7% from $68,293 a year earlier.

Analysis

Quantum Biopharma (QNTM) Gains from Sales and Divestitures (2025) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Quantum Biopharma's Gains from Sales and Divestitures came in at -$175,215; for FY2025, it was -$175,194.

  • Five-year quarterly Gains from Sales and Divestitures spans a low of -$175,194 in Q3 2025 and a high of $68,293 in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 Quantum Biopharma 8.71 Mn -3.49 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 350,388.00
Sep 30, 2025 -175,194.00
API Access

Quantum Biopharma Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=QNTM&period=max&api_key=YOUR_API_KEY